Pages that link to "Q46513852"
Jump to navigation
Jump to search
The following pages link to AML patients with Down syndrome have a high cure rate with AML-BFM therapy with reduced dose intensity (Q46513852):
Displaying 50 items.
- The biology of pediatric acute megakaryoblastic leukemia (Q26799478) (← links)
- Acute Erythroleukemias, Acute Megakaryoblastic Leukemias, and Reactive Mimics: A Guide to a Number of Perplexing Entities (Q26851821) (← links)
- Prognosis and management of acute myeloid leukemia in patients with Down syndrome (Q27016577) (← links)
- Myeloid leukemia in Down syndrome (Q27027258) (← links)
- Transient Abnormal Myelopoiesis and AML in Down Syndrome: an Update (Q28079980) (← links)
- Transcription factor GATA-1 and Down syndrome leukemogenesis (Q28251869) (← links)
- Treatment and prognostic impact of transient leukemia in neonates with Down syndrome (Q33378192) (← links)
- LincRNAs MONC and MIR100HG act as oncogenes in acute megakaryoblastic leukemia (Q33986195) (← links)
- The presence of central nervous system disease at diagnosis in pediatric acute myeloid leukemia does not affect survival: a Children's Oncology Group study (Q34344493) (← links)
- Identification of distinct molecular phenotypes in acute megakaryoblastic leukemia by gene expression profiling. (Q34480244) (← links)
- Down syndrome and malignancies: a unique clinical relationship: a paper from the 2008 william beaumont hospital symposium on molecular pathology (Q34611232) (← links)
- Acute megakaryoblastic leukaemia (AMKL) in children: a comparison of AMKL with and without Down syndrome (Q34750189) (← links)
- Differential gene expression, GATA1 target genes, and the chemotherapy sensitivity of Down syndrome megakaryocytic leukemia. (Q35848677) (← links)
- Anthracycline-Related Cardiotoxicity in Patients with Acute Myeloid Leukemia and Down Syndrome: A Literature Review (Q35888110) (← links)
- Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia (Q36053792) (← links)
- Myeloid Proliferations Associated with Down Syndrome (Q36440331) (← links)
- An Inv(16)(p13.3q24.3)-encoded CBFA2T3-GLIS2 fusion protein defines an aggressive subtype of pediatric acute megakaryoblastic leukemia (Q36541505) (← links)
- Normal and malignant megakaryopoiesis (Q36909019) (← links)
- Haematology of Down syndrome (Q36931357) (← links)
- Outcome of transplantation for acute myelogenous leukemia in children with Down syndrome (Q37000896) (← links)
- Cardiomyopathy in children with Down syndrome treated for acute myeloid leukemia: a report from the Children's Oncology Group Study POG 9421. (Q37059586) (← links)
- Hematopoietic Stem Cells from Ts65Dn Mice Are Deficient in the Repair of DNA Double-Strand Breaks (Q37090261) (← links)
- Constitutional aneuploidy and cancer predisposition (Q37134129) (← links)
- Insights into the manifestations, outcomes, and mechanisms of leukemogenesis in Down syndrome (Q37142140) (← links)
- The role of the proto-oncogene ETS2 in acute megakaryocytic leukemia biology and therapy (Q37259709) (← links)
- RUNX1 regulates phosphoinositide 3-kinase/AKT pathway: role in chemotherapy sensitivity in acute megakaryocytic leukemia. (Q37372829) (← links)
- Malignancy in children with trisomy 21. (Q37379570) (← links)
- Favorable survival maintained in children who have myeloid leukemia associated with Down syndrome using reduced-dose chemotherapy on Children's Oncology Group trial A2971: a report from the Children's Oncology Group (Q37427903) (← links)
- Normal karyotype is a poor prognostic factor in myeloid leukemia of Down syndrome: a retrospective, international study. (Q37552027) (← links)
- Histone deacetylase inhibitors induce apoptosis in myeloid leukemia by suppressing autophagy (Q37626910) (← links)
- Mosaic Down syndrome-associated acute myeloid leukemia does not require high-dose cytarabine treatment for induction and consolidation therapy (Q37711118) (← links)
- Genetic aberrations in paediatric acute leukaemias and implications for management of patients. (Q37740701) (← links)
- Unique clinical and biological features of leukemia in Down syndrome children (Q37810271) (← links)
- Molecular diagnosis and risk-adjusted therapy in pediatric hematologic malignancies: a primer for pediatricians (Q37847072) (← links)
- Children's Oncology Group's 2013 blueprint for research: acute myeloid leukemia (Q38068816) (← links)
- Overview of therapy and strategies for optimizing outcomes in de novo pediatric acute myeloid leukemia (Q38196743) (← links)
- Child and adolescent Down syndrome-associated leukaemia: the Irish experience. (Q38262596) (← links)
- Improved outcomes for myeloid leukemia of Down syndrome: a report from the Children's Oncology Group AAML0431 trial (Q38733360) (← links)
- Infectious Complications in Children With Acute Myeloid Leukemia and Down Syndrome: Analysis of the Prospective Multicenter Trial AML-BFM 2004. (Q38915719) (← links)
- Pediatric non-Down syndrome acute megakaryoblastic leukemia is characterized by distinct genomic subsets with varying outcomes. (Q39005643) (← links)
- Treatment for myeloid leukaemia of Down syndrome: population-based experience in the UK and results from the Medical Research Council AML 10 and AML 12 trials. (Q40354450) (← links)
- Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials (Q40370520) (← links)
- Preserved High Probability of Overall Survival with Significant Reduction of Chemotherapy for Myeloid Leukemia in Down Syndrome: A Nationwide Prospective Study in Japan. (Q41203406) (← links)
- Infections in children with down syndrome and acute myeloid leukemia: a report from the Canadian infections in AML research group (Q42012900) (← links)
- Acute leukemia in children with Down syndrome (Q42739970) (← links)
- Constitutional chromosomal abnormality identified in a sibling donor after bone marrow stem cell transplantation in a pediatric patient with acute megakaryoblastic leukemia. (Q43074730) (← links)
- Blast cell deficiency of CD11a as a marker of acute megakaryoblastic leukemia and transient myeloproliferative disease in children with and without Down syndrome (Q46145690) (← links)
- Long noncoding RNAs in hematopoietic malignancies (Q46191604) (← links)
- Risk factors for early death in neonates with Down syndrome and transient leukaemia (Q46569123) (← links)
- Single-cell whole exome and targeted sequencing in NPM1/FLT3 positive pediatric acute myeloid leukemia. (Q47579484) (← links)